Dr. Gersh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 S Sherman St
Spokane, WA 99202Phone+1 509-228-1000Fax+1 509-252-9300
Education & Training
Emory University School of MedicineResidency, Internal Medicine, 1975 - 1980
University of Colorado School of Medicine Anschutz Medical CampusClass of 1975
Certifications & Licensure
WA State Medical License 1980 - 2021
ID State Medical License 2012 - 2020
GA State Medical License 1977 - 1981
Publications & Presentations
PubMed
- 43 citationsGemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative studyDonald A. Richards, Paul R. Kuefler, Carlos Becerra, Lalan S. Wilfong, Robert H. Gersh
Investigational New Drugs. 2011-02-01 - 214 citationsHematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic SyndromesRoger M. Lyons, Thomas Cosgriff, Sanjiv Modi, Robert H. Gersh, John D. Hainsworth
Journal of Clinical Oncology. 2009-04-10 - 37 citationsα-Difluoromethylornithine as Treatment for Metastatic Breast Cancer PatientsJoyce O'Shaughnessy, Laurence M. Demers, Stephen E. Jones, James Arseneau, Pankaj Khandelwal
Clinical Cancer Research. 1999-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
